Latest news
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.stsimplywall.st · Mon, 10 Aug 2026 11:10:52 GMTEquities Analysts Issue Forecasts for NTLA Q2 Earnings - MarketBeatMarketBeat · Mon, 10 Aug 2026 05:51:17 GMTNTLA Stock Rockets After Hours Before Critical Data For Genetic Disorder Therapy - StocktwitsStocktwits · Sat, 08 Aug 2026 16:17:22 GMTBank of America Securities Remains a Hold on Intellia Therapeutics (NTLA) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 10:58:00 GMTWhy Is NTLA Stock Jumping 5% Premarket Today? - StocktwitsStocktwits · Sat, 08 Aug 2026 08:06:47 GMTNTLA Stock Surges 35% Overnight: Retail Mood Peaks Ahead Of First-Ever Phase 3 Readout For Gene-Editing Therapy - StocktwitsStocktwits · Sat, 08 Aug 2026 00:56:52 GMTNTLA Jumps Premarket On Positive Late-Stage Trial Data For Gene-Editing Therapy — Retail Says Buy Now Before It’s Too Late - StocktwitsStocktwits · Fri, 07 Aug 2026 22:50:17 GMTIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 20:01:00 GMT